The Legal Examiner Mark The Legal Examiner Mark The Legal Examiner Mark search twitter facebook feed linkedin instagram google-plus avvo phone envelope checkmark mail-reply spinner error close
Skip to main content

Considering medication to combat low testosterone? You may want a second opinion.

A new study has found that testosterone drugs, designed at boosting testosterone or “T” levels in men, may increase your chance of heart problems, stroke and even death.

Researchers have found a link between testosterone drugs and heart attack, stroke and other cardiovascular events. The incidence of events nearly tripled in patients younger than 65 with a history of heart disease. The study also found patients over 65 had a two-fold risk.

The study is changing the conversation about Low T and prompting the U.S. Food and Drug Administration (FDA) to reassess the risk of prescription testosterone drugs.

“Due to the size of our study, we were able to examine heart attacks, as opposed to a variety of cardiovascular conditions, and we were able to examine excess risk in the short term,” said William Finkle, the lead author and an epidemiologist at Consolidated Research, a statistics and software development firm. “Our study is also the first to include a substantial number of men under 65″

Many recommend further studies to better understand the benefits and risks of Low T therapy and how it can be used safely and effectively. For now, the risk remains.

Testosterone Product Names:

  • Androgel
  • Androderm
  • Axiron
  • Bio-T-Gel
  • Delatestryl
  • Depo-Testosterone
  • Fortesta
  • Striant
  • Testim
  • Testopela

If you or someone you love has been taking any of the above testosterone products and suffered a cardiovascular event, it is important that you seek medical and legal advice immediately.

Comments are closed.

Of Interest